cardiovascular system
• tamoxifen-treated mice exhibit increased radial length (1.5-fold), vascular density (1.6-fold), vessel diameter (1.9-fold), endothelial cell proliferative activity (2.0-fold) and sprouting activity (1.8-fold) compared with control mice
|
• 2.4-fold decreased vessel leakage following oxygen-induced retinopathy in tamoxifen-treated mice
|
vision/eye
• tamoxifen-treated mice exhibit increased radial length (1.5-fold), vascular density (1.6-fold), vessel diameter (1.9-fold), endothelial cell proliferative activity (2.0-fold) and sprouting activity (1.8-fold) compared with control mice
|
• following oxygen-induced retinopathy, mice exhibit decreased avascular area, neovascular tuft area and increased pericyte coverage in the superficial layer with more densely networked vessels in the central and middle regions of the deep layer, 2.4-fold decreased vessel leakage and 8.6-fold decrease in multifocal hemorrhages compared with control mice
|
nervous system
• 1.3-fold increase in GFAP+ cell densities in tamoxifen-treated mice
• however, the number of Pax2+ astrocytes is normal
|
homeostasis/metabolism
• following oxygen-induced retinopathy, mice exhibit decreased avascular area, neovascular tuft area and increased pericyte coverage in the superficial layer with more densely networked vessels in the central and middle regions of the deep layer, 2.4-fold decreased vessel leakage and 8.6-fold decrease in multifocal hemorrhages compared with control mice
|